Skip to main content

Current Regulatory Environment of Herbal Medicinal Products in the European Union

  • Chapter
  • First Online:

Abstract

In the Member States of the European Union, there have been diverse traditions with respect to usage of medicinal plants, and different approaches were followed at the national level. In order to harmonize assessment of herbal medicinal products and to facilitate access to the market in different Member States of the European Union, a common law was enforced in the European Union. The legal framework provided a set of basic definitions, laid down the options to grant access to the market and set the basic framework to have common standards and requirements for herbal medicinal products in the European Union. A Committee on Herbal Medicinal Products (HMPC) was established at the European Medicines Agency in 2004. The most important task of the HMPC is the development of European Union monographs which recommend harmonized standard for safety and efficacy of herbal substances and preparations thereof. With respect to the existing level of evidence, monographs are addressing a well-established use or if the evidence is not sufficient a traditional use. The HMPC is an excellent model how scientific evaluation of herbal medicines can be harmonized and set accepted and science-based standards to ensure public health.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Abbreviations

CTD:

Common Technical Document

DCP:

Decentralized procedure

EC:

European Community

EDQM:

European Directorate for Quality of Medicines & Health Care

EMA:

European Medicines Agency

GCP:

Good Clinical Practice

HMPC:

Committee on Herbal Medicinal Products

MLWP:

Working Party on Community Monographs and List Entries

MRP:

Mutual Recognition Procedure

ORGAM DG:

Organizational Matters Drafting Group

Q DG:

Quality Drafting Group

TCM:

Traditional Chinese medicine

References

  • Blumenthal M, Busse WR, Goldberg A, Gruenwald J et al (eds) (1998) The complete German Commission E monographs. American Botanical Council, Austin

    Google Scholar 

  • Consolidated Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use as amended by Directive 2002/98/EC, Directive 2003/63/EC, Directive 2004/24/EC, Directive 2004/27/EC and Directive 2008/29/EC

    Google Scholar 

  • Directive 2004/24/EC of the European Parliament and of the Council of 31 March 2004 amending, as regards traditional herbal medicinal products, Directive 2001/83/EC on the Community code relating to medicinal products for human use

    Google Scholar 

  • ESCOP Monographs.1st and 2nd edition and supplements (2009). European Scientific Cooperative on Phytotherapy, editor. Georg Thieme, Stuttgart

    Google Scholar 

  • European Medicines Agency: http://www.ema.europa.eu – Regulatory – Human medicines

  • European Pharmacopeia 9th edition (2016). EDQM, Strasbourg

    Google Scholar 

  • ‘Marketing Authorisation’, the Rules governing medicinal products in the European Community, notice to applicants, Volume 2A, Chapter 1; EU Pharmaceutical legislation – EudraLex Volume 1

    Google Scholar 

  • Regulation (EC) no 726/2004 of the European Parliament and of the council of 31 March 2004 laying down community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European medicines agency

    Google Scholar 

  • Regulation (EC) Nr. 1901/2006 of the European Parliament and of the council of 12 December 2006 on medicinal products for paediatric use

    Google Scholar 

  • WHO monographs on selected medicinal plants. Volumes 1, 2, 3 and 4 (2009). World Health Organisation, Geneva

    Google Scholar 

Download references

Conflict of Interest

The views expressed in this article are the views of the authors and may not be understood or quoted as being made on behalf of or reflecting the position of the European Medicines Agency or one of its committees or working parties. There is no conflict of interest.

The data and figures provided are based on data available in April 2018.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Werner Knöss .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Knöss, W. (2018). Current Regulatory Environment of Herbal Medicinal Products in the European Union. In: Cechinel Filho, V. (eds) Natural Products as Source of Molecules with Therapeutic Potential. Springer, Cham. https://doi.org/10.1007/978-3-030-00545-0_10

Download citation

Publish with us

Policies and ethics